NO20001196D0 - Nootropisk middel - Google Patents
Nootropisk middelInfo
- Publication number
- NO20001196D0 NO20001196D0 NO20001196A NO20001196A NO20001196D0 NO 20001196 D0 NO20001196 D0 NO 20001196D0 NO 20001196 A NO20001196 A NO 20001196A NO 20001196 A NO20001196 A NO 20001196A NO 20001196 D0 NO20001196 D0 NO 20001196D0
- Authority
- NO
- Norway
- Prior art keywords
- nootropic agent
- nootropic
- agent
- Prior art date
Links
- 239000002664 nootropic agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9249131A JPH1180027A (ja) | 1997-09-12 | 1997-09-12 | 向知性薬 |
| PCT/JP1998/004136 WO1999013911A1 (en) | 1997-09-12 | 1998-09-14 | Nootropic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001196D0 true NO20001196D0 (no) | 2000-03-08 |
| NO20001196L NO20001196L (no) | 2000-05-10 |
Family
ID=17188397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001196A NO20001196L (no) | 1997-09-12 | 2000-03-08 | Nootropisk middel |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1022029A1 (no) |
| JP (1) | JPH1180027A (no) |
| KR (1) | KR20010030582A (no) |
| CN (1) | CN1270528A (no) |
| AU (1) | AU9003598A (no) |
| BR (1) | BR9815370A (no) |
| CA (1) | CA2301782A1 (no) |
| ID (1) | ID24282A (no) |
| IL (1) | IL134661A0 (no) |
| NO (1) | NO20001196L (no) |
| WO (1) | WO1999013911A1 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW544311B (en) * | 1998-08-06 | 2003-08-01 | Daiichi Seiyaku Co | Therapeutic or preventive agent for intractable epilepsies |
| CA2374921A1 (en) * | 1999-05-31 | 2000-12-07 | Shigeo Watabe | Neuronal death inhibitors |
| GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| US6423739B1 (en) | 2000-02-23 | 2002-07-23 | Daiichi Pharmaceutical Co., Ltd. | Method for aiding cerebral recovery following neurodegeneration |
| US6348489B1 (en) * | 2000-04-11 | 2002-02-19 | Daiichi Pharmaceutical Co., Ltd. | Method of treating traumatic brain injury and other neuronal disorders |
| GB0021885D0 (en) * | 2000-09-06 | 2000-10-18 | Fujisawa Pharmaceutical Co | New use |
| ES2311537T3 (es) * | 2001-08-22 | 2009-02-16 | Hamilton Pharmaceuticals, Inc. | Utilizacion de nefiracetam en el tratamiento de la neurodegeneracion postquemica. |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| AU2009316557B2 (en) | 2008-11-19 | 2015-08-27 | Envivo Pharmaceuticals, Inc. | Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl) benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
| CA2799744C (en) | 2010-05-17 | 2020-01-28 | Envivo Pharmaceuticals, Inc. | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
| US9585877B2 (en) | 2012-05-08 | 2017-03-07 | Forum Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
| JP6066312B2 (ja) * | 2013-03-29 | 2017-01-25 | 国立研究開発法人理化学研究所 | 細胞膜片を備えた発電素子および発電デバイス |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA923134B (en) * | 1991-05-02 | 1993-01-27 | Daiichi Seiyaku Co | Agent for improving dementia |
| JP3388778B2 (ja) * | 1991-05-02 | 2003-03-24 | 第一製薬株式会社 | 脳血管性痴呆改善剤 |
| JPH06279311A (ja) * | 1993-03-26 | 1994-10-04 | Sagami Chem Res Center | プロテインキナーゼcアイソザイムの活性化剤 |
-
1997
- 1997-09-12 JP JP9249131A patent/JPH1180027A/ja active Pending
-
1998
- 1998-09-14 EP EP98941864A patent/EP1022029A1/en not_active Withdrawn
- 1998-09-14 KR KR1020007002597A patent/KR20010030582A/ko not_active Ceased
- 1998-09-14 ID IDW20000459A patent/ID24282A/id unknown
- 1998-09-14 WO PCT/JP1998/004136 patent/WO1999013911A1/ja not_active Ceased
- 1998-09-14 CN CN98809035A patent/CN1270528A/zh active Pending
- 1998-09-14 AU AU90035/98A patent/AU9003598A/en not_active Abandoned
- 1998-09-14 IL IL13466198A patent/IL134661A0/xx unknown
- 1998-09-14 BR BR9815370-6A patent/BR9815370A/pt not_active IP Right Cessation
- 1998-09-14 CA CA002301782A patent/CA2301782A1/en not_active Abandoned
-
2000
- 2000-03-08 NO NO20001196A patent/NO20001196L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20001196L (no) | 2000-05-10 |
| CA2301782A1 (en) | 1999-03-25 |
| ID24282A (id) | 2000-07-13 |
| JPH1180027A (ja) | 1999-03-23 |
| EP1022029A1 (en) | 2000-07-26 |
| KR20010030582A (ko) | 2001-04-16 |
| AU9003598A (en) | 1999-04-05 |
| WO1999013911A1 (en) | 1999-03-25 |
| CN1270528A (zh) | 2000-10-18 |
| BR9815370A (pt) | 2000-10-24 |
| IL134661A0 (en) | 2001-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69807652D1 (de) | Rasiersystem | |
| DE69804210D1 (de) | Rasiereinheit | |
| MX208461B (es) | Polisacaridos de termofraguado | |
| NO20000604L (no) | Aryloksyarylsulfonylaminohydroksaminosyrederivater | |
| DE59801355D1 (de) | Schere | |
| DE69803632D1 (de) | Einpressmutter | |
| DE69817671D1 (de) | Antragsrolle | |
| NO984771D0 (no) | F°lgesystem | |
| ID20285A (id) | Katrol tangan | |
| NO20001196D0 (no) | Nootropisk middel | |
| NO995147D0 (no) | Kontrastmidler | |
| DE59801498D1 (de) | Dioxacycloalkan-8-one | |
| DK0888962T3 (da) | Fremdrivningsenhed | |
| FIU970017U0 (fi) | Putkiperustus | |
| FI974271A0 (fi) | Abonnentlinjekrets | |
| NO981689D0 (no) | Naftylpiperasinderivater | |
| FI972138A0 (fi) | Returtraog i bestrykningsanordning | |
| KR970016519U (ko) | 가위 | |
| FIU970152U0 (fi) | Avarrusohjuri | |
| ITMI981551A0 (it) | Fenilazoaniline | |
| NO974138D0 (no) | Kontrastmidler | |
| KR970051149U (ko) | 여러가지 돌아이바이 | |
| PT9429T (pt) | Gaita de foles | |
| KR970057221U (ko) | 가위 | |
| FI974373A0 (fi) | Avgasutlopp i utombordsmotorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |